# Evaluation of Tomosynthesis for Characterization and the Management of Breast Lesions

> **NCT02959398** · NA · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 2000 (estimated)

## Conditions studied

- Breast Neoplasms
- Tomosynthesis
- BRCA1 Protein
- BRCA2 Protein

## Interventions

- **DEVICE:** Standard mammography
- **DEVICE:** Standard mammography and tomosynthesis

## Key facts

- **NCT ID:** NCT02959398
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-20
- **Primary completion:** 2020-05
- **Final completion:** 2021-05
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2017-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02959398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02959398, "Evaluation of Tomosynthesis for Characterization and the Management of Breast Lesions". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02959398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*